Clinical trial
An Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
NCT07303790 is registered in ClinicalTrials.gov with Daishi Tian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
- Lead sponsor
- Daishi Tian
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 9, 2026
- Completion date
- December 10, 2028
- Enrollment
- 9 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.